199 related articles for article (PubMed ID: 29924454)
41. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
42. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.
Yasui K; Kondou R; Iizuka A; Miyata H; Tanaka E; Ashizawa T; Nagashima T; Ohshima K; Urakami K; Kusuhara M; Muramatsu K; Sugino T; Yamguchi K; Mori K; Harada H; Nishimura T; Kagawa H; Yamakawa Y; Hino H; Shiomi A; Akiyama Y
J Radiat Res; 2020 Sep; 61(5):766-775. PubMed ID: 32672335
[TBL] [Abstract][Full Text] [Related]
43. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
Weygant N; Qu D; May R; Tierney RM; Berry WL; Zhao L; Agarwal S; Chandrakesan P; Chinthalapally HR; Murphy NT; Li JD; Sureban SM; Schlosser MJ; Tomasek JJ; Houchen CW
Oncotarget; 2015 Feb; 6(4):2193-205. PubMed ID: 25605241
[TBL] [Abstract][Full Text] [Related]
44. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.
Kadletz L; Aumayr K; Heiduschka G; Schneider S; Enzenhofer E; Lill C
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):467-475. PubMed ID: 27470117
[TBL] [Abstract][Full Text] [Related]
46. Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer.
Li N; Dou L; Zhang Y; Jin J; Wang G; Xiao Q; Li Y; Wang X; Ren H; Fang H; Wang W; Wang S; Liu Y; Song Y
Gastrointest Endosc; 2017 Mar; 85(3):669-674. PubMed ID: 27354104
[TBL] [Abstract][Full Text] [Related]
47. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
48. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
49. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
50. Number of Lymph Nodes in Rectal Cancer is Correlated with Response to Preoperative Chemoradiotherapy but is not Associated with Patient Survival.
Ishihara S; Fukushima Y; Akahane T; Horiuchi A; Shimada R; Nakamura K; Aoyagi Y; Hayama T; Yamada H; Nozawa K; Matsuda K; Hashiguchi Y; Watanabe T
Hepatogastroenterology; 2014 Jun; 61(132):1000-7. PubMed ID: 26158156
[TBL] [Abstract][Full Text] [Related]
51. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.
Caramés C; Cristobal I; Moreno V; Marín JP; González-Alonso P; Torrejón B; Minguez P; Leon A; Martín JI; Hernández R; Pedregal M; Martín MJ; Cortés D; García-Olmo D; Fernández MJ; Rojo F; García-Foncillas J
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271609
[TBL] [Abstract][Full Text] [Related]
53. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
[TBL] [Abstract][Full Text] [Related]
54. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
[TBL] [Abstract][Full Text] [Related]
55. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
56. [Association between primary tumor regression and lymph node status after neoadjuvant chemoradiotherapy in mid and low rectal cancer].
Chen G; Cui W; Li SY; Yu B
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):961-3. PubMed ID: 22205459
[TBL] [Abstract][Full Text] [Related]
57. Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer.
Azizian A; Kramer F; Jo P; Wolff HA; Beißbarth T; Skarupke R; Bernhardt M; Grade M; Ghadimi BM; Gaedcke J
World J Surg; 2015 Sep; 39(9):2329-35. PubMed ID: 25990502
[TBL] [Abstract][Full Text] [Related]
58. Increase in Gene Expression of TYMP, DPYD and HIF1A Are Associated with Response to Preoperative Chemoradiotherapy Including S-1 or UFT for Rectal Cancer.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Saito G; Kamijo A; Nagase H
Anticancer Res; 2016 May; 36(5):2433-40. PubMed ID: 27127154
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.
Azizian A; Epping I; Kramer F; Jo P; Bernhardt M; Kitz J; Salinas G; Wolff HA; Grade M; Beißbarth T; Ghadimi BM; Gaedcke J
Int J Mol Sci; 2016 Apr; 17(4):568. PubMed ID: 27092493
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.
Huh JW; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim HC; Park HC; Choi DH; Park JO; Park YS; Chun HK
Yonsei Med J; 2015 Jan; 56(1):82-8. PubMed ID: 25510750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
